Suchergebnisse - "Vrancken Peeters, Marie-Jeanne T F D"

PubPharm (13)

1

Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer : a nationwide cohort analysis of pathologic response and 5-year survival

enthalten in: Breast (Edinburgh, Scotland) | 2022

von van der Voort, A. | Liefaard, M. | van Ramshorst, M. | +8

2

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer

enthalten in: Breast cancer research and treatment | 2021

von Groen, E. | van der Noordaa, M. | Schaapveld, M. | +7

3

Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial) : Interim Analysis of a Multicenter Observational Cohort Study

enthalten in: Annals of surgical oncology | 2021

von van Loevezijn, A. | van der Noordaa, M. | van Werkhoven, E. | +10

4

Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer : The TRAIN-study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2017

von van Ramshorst, M. | van Werkhoven, E. | Mandjes, I. | +9

5

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes

enthalten in: PloS one | 2017

von Schmitz, A. | Teixeira, S. | Pengel, K. | +9

6

Sequential (18)F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2014

von Koolen, B. | Pengel, K. | Wesseling, J. | +7

7

FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer

enthalten in: Breast (Edinburgh, Scotland) | 2013

von Koolen, B. | Pengel, K. | Wesseling, J. | +7

8

Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer : implications for surgical management of the axilla

enthalten in: Annals of surgical oncology | 2013

von Koolen, B. | Valdés Olmos, R. | Wesseling, J. | +6

CommentIn: Ann Surg Oncol. 2014 Feb;21(2):700. - PMID 24052316

9

SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer

enthalten in: Breast cancer research and treatment | 2013

von de Ronde, J. | Lips, E. | Mulder, L. | +8

10

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer

enthalten in: Breast cancer research and treatment | 2012

von Lips, E. | Mukhtar, R. | Yau, C. | +13